CBP-246

N/A

Report date: 2023/10/07 14:47:50

Base Information

Drug NameCBP-246
Drug Alias NameCBP-246
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Interleukin-1 receptor accessory protein
TargetsInterleukin-1 receptor accessory protein
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Connect Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Connect Biopharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A